Skip to main content

The Green Organic Dutchman Holdings Ltd (TGOD-T) Quote

Unchecking box will stop auto data updates
TSX Real-Time Last Sale CAD
Today's Change
Volume
Price Quote as of

Today's Trading

Day Low 3.20
Day High 3.30
Open:3.30
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change

More stories below advertisement

Description
The Green Organic Dutchman Holdings Ltd through its subsidiary operates as a cannabinoid-based research and development company in Canada. The company has two operating segments namely production and distribution of cannabis and related products and Hemp related products. It produces organic cannabis products, including organic dried cannabis, cannabis oils and edibles, fresh cannabis, and seeds for medical applications. Geographically, it generates maximum revenue from Europe.

Fundamentals

Market Capitalization, $M
Shares Outstanding, M
36-Month Beta
Earnings Per Share (TTM)
Revenue Growth YoY
Profit Margin
5-Year Avg. Revenue Growth
5-Year Avg. Profit Growth
1-Year Total Return
3-Year Total Return
5-Year Total Return
Price/Earnings (TTM)
Price/Earnings (Forward)
Trailing Annual Dividend & Yield
Forward Annual Dividend & Yield
Most Recent Dividend
Ex-Div Date
Most Recent Split
Return on Common Equity
Return-on-Assets (Before Tax)
Debt-to-Equity Ratio
Price/Book

Earnings

Corporate earnings are provided from Morningstar, including Income Statements,Balance Sheets, Cash Flow Statements, and Statement of Retained Earnings.

Analyst Research

Analyst Ratings and Earnings Estimates are provided by Zacks Investment Research – including Buy/Hold Recommendations, Earnings Surprises, Estimates and Recommendations History.

Stock Reports +

Download a comprehensive report detailing quantitative analytics of this equity. For subscribers only.

StockCalc Reports

Download a comprehensive report detailing quantitative analytics of this equity. For subscribers only.

Latest Press Releases

Shifting Cannabis Regulations Signal New Potential for the Industry
PR Newswire - Wed Jul 17, 8:00AM CDT
PR Newswire - CMTX
Wed Jul 17, 8:00AM CDT
The cannabis industry experienced uplifting news after the U.S. Food and Drug Administration announced it is expediting processes to address the matter regarding cannabidiol or CBD. FDA Principal Deputy Commissioner and Acting Chief Information Officer Amy Abernethy announced in a series of tweets that the matter is an "important national issues with public health impact." Moreover, Abernethy says that the FDA is enthusiastic about researching regarding the therapeutic benefits of CBD products. Similarly, former FDA commissioner Scott Gottlieb also made it a goal to expedite research regarding CBD. The conjoined efforts of the public and the FDA ultimately led to the passage of the U.S. Farm Bill and the descheduling of CBD by the U.S. Drug Enforcement Administration. Additionally, the FDA approved the use of Epidiolex, a CBD-based drug, to treat epilepsy common among children. Following the passage, CBD products rapidly emerged throughout the U.S. from local brick-and-mortar stores to giant e-commerce portals. However, the FDA has made it clear that the addition of CBD in foods and beverages is still prohibited. Nonetheless, consumers can still obtain these health and wellness products containing CBD in some areas. Furthermore, CBD has also become prevalent in nations such as Australia, Chile, Colombia, France, Germany, and Spainas they have legalized cannabis for medical applications. Primarily, most of the regions are using CBD to treat patients suffering from conditions such as multiple sclerosis, cancer, chronic pain, epilepsy, and depression. While the CBD marketplace is thriving globally, the THC market is experiencing growth in regions where recreational cannabis is legal. Overall, the combination of the two markets is causing the broader cannabis industry to undergo exponential growth and development. According to data compiled by Mordor Intelligence, the global cannabis industry was valued at USD 14.5 Billion in 2018. By 2024, the market is expected to reach USD 89.1 Billion while registering a CAGR of 37% during the forecast period from 2019 to 2024. MediPharm Labs Corp. (OTC: MEDIF) (TSX-V: LABS), Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON), Aurora Cannabis Inc. (NYSE: ACB) (TSX: ACB), The Green Organic Dutchman Holdings Ltd. (OTC: TGODF) (TSX: TGOD), Charlotte's Web Holdings, Inc. (OTC: CWBHF) (TSX: CWEB)
With 10,000 Licenses Issued, California Reflects the Growing Power of Hemp
PR Newswire - Tue Jul 16, 7:30AM CDT
PR Newswire - CMTX
Tue Jul 16, 7:30AM CDT
As hemp production increases, Californian legislators have extended the duration of thousands of cannabis cultivation licenses to support the state's thriving industry.
Alcohol Consumption Drops With Cannabis Legalization Abound
PR Newswire - Fri Jul 12, 8:00AM CDT
PR Newswire - CMTX
Fri Jul 12, 8:00AM CDT
The steady decrease in alcohol consumption has led consumers to find new alternatives. And specifically, the rise of cannabis is directly correlated with declining alcohol consumption rates. Investment bank firm Cowen & Co. reported that legal adult use cannabis states witnessed binge drinking rates fall by 9% below the national average, and 11% below non-cannabis states. However, newly added states such as California and Nevada currently have higher rates of binge drinking intensity and lower levels of cannabis consumption. As a result, Cowen said it is reasonable to assume that as more states legalize adult use cannabis, the alcohol binge drinking rates will begin to falter. The Centers for Disease Control and Prevention estimated that 17% of the U.S. population engaged in binge drinking, meaning that 1 in 6 reported doing so 4 or more times a month. In states that legalized adult use, the number of binge drinking sessions per month was 9% below the national average. In particular, many millennials have opted to consume cannabis over drinking alcohol. For instance, according to a MarketWatch article, a millennial said that she prefers to consume cannabis over alcohol because it saves her more money and doesn't cause intoxicating effects of alcohol. According to a Yahoo News poll in 2017, it was concluded that the majority of the 55 million recreational marijuana users in the U.S. are millennials. Meanwhile, a national survey conducted by the Monitoring the Future Study uncovered that the share of college students drinking alcohol daily fell from 4.3% in 2016 to 2.2% in 2017. Furthermore, Cowen & Co. analysts project the U.S. cannabis market to reach sales of approximately USD 75 Billion by 2030. And while the U.S. accounts for a majority of the global cannabis market share, other regions are rapidly emerging and witnessing faster growth rates. Pasha Brands Ltd. (OTC: CRFTF) (CSE: CRFT), Aurora Cannabis Inc. (NYSE: ACB) (TSX: ACB), Aphria Inc. (NYSE: APHA) (TSX: APHA), Organigram Holdings Inc. (NASDAQ: OGI) (TSX-V: OGI), The Green Organic Dutchman Holdings Ltd. (OTC: TGODF) (TSX: TGOD).
Price History Describes more index sector components

Price Performance

Period Period Low Period High Performance
1-Month 3.06 +5.88% increase
on 07/15/19
Period Open:3.27
Price movement based on the high, low and last over the given period.
3.42 -5.26% decrease
on 06/20/19
-0.03 (-0.92%) decrease
since 06/19/19
3-Month 3.06 +5.88% increase
on 07/15/19
Period Open:3.91
Price movement based on the high, low and last over the given period.
4.63 -30.02% decrease
on 05/01/19
-0.67 (-17.14%) decrease
since 04/18/19
52-Week 2.19 +47.95% increase
on 12/27/18
Period Open:5.83
Price movement based on the high, low and last over the given period.
10.24 -68.36% decrease
on 09/19/18
-2.59 (-44.43%) decrease
since 07/19/18

More stories below advertisement

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2019.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).